ATC code A08 (original) (raw)

From Wikipedia, the free encyclopedia

Pharmaceutical drug classification

ATC code A08 Antiobesity preparations, excluding diet products is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup A08 is part of the anatomical group A Alimentary tract and metabolism.[4]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QA08.[5] ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.
National versions of the ATC classification may include additional codes not present in this list, which follows the WHO version.

A08AA01 Phentermine

A08AA02 Fenfluramine

A08AA03 Amfepramone

A08AA04 Dexfenfluramine

A08AA05 Mazindol

A08AA06 Etilamfetamine

A08AA07 Cathine

A08AA08 Clobenzorex

A08AA09 Mefenorex

A08AA10 Sibutramine

A08AA11 Lorcaserin

A08AA12 Setmelanotide

A08AA51 Phentermine and topiramate

A08AA56 Ephedrine, combinations

A08AA62 Bupropion and naltrexone

A08AB01 Orlistat

QA08AB90 Mitratapide

QA08AB91 Dirlotapide

A08AX Other antiobesity drugs

[edit]

A08AX01 Rimonabant

• Diet products are in the ATC group V06A.

1. ^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
2. ^ "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
3. ^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
4. ^ "ATC/DDD Index 2022: code A08". WHO Collaborating Centre for Drug Statistics Methodology.
5. ^ "ATCvet Index 2022: code QA08". WHO Collaborating Centre for Drug Statistics Methodology.